EUVIMEDEUVIMED entdecken
Crossref

Benefit of switching dual antiplatelet therapy after ACS on dual antiplatelet therapy adherence: A prespecified analysis of the TOPIC randomized study

P. Deharo, J. Quilci, C. Bassez, G. Bonnet, M. Lambert, P. Morange, M.C. Alessi, L. Fourcade, J. Bonnet, T. Cuisset

Archives of Cardiovascular Diseases Supplements · 2018

DOI: 10.1016/j.acvdsp.2017.11.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Cardiovascular Diseases Supplements, 2018. Verfasst von P. Deharo und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Deharo, P., Quilci, J., Bassez, C., Bonnet, G., Lambert, M., Morange, P., Alessi, M., Fourcade, L., Bonnet, J., & Cuisset, T. (2018). Benefit of switching dual antiplatelet therapy after ACS on dual antiplatelet therapy adherence: A prespecified analysis of the TOPIC randomized study. Archives of Cardiovascular Diseases Supplements. https://doi.org/10.1016/j.acvdsp.2017.11.010

Vancouver

Deharo P, Quilci J, Bassez C, Bonnet G, Lambert M, Morange P, et al. Benefit of switching dual antiplatelet therapy after ACS on dual antiplatelet therapy adherence: A prespecified analysis of the TOPIC randomized study. Archives of Cardiovascular Diseases Supplements. 2018. doi:10.1016/j.acvdsp.2017.11.010

BibTeX
@article{Deharo2018,
  author = {Deharo, P. and Quilci, J. and Bassez, C. and Bonnet, G. and Lambert, M. and Morange, P. and Alessi, M.C. and Fourcade, L. and Bonnet, J. and Cuisset, T.},
  title = {Benefit of switching dual antiplatelet therapy after ACS on dual antiplatelet therapy adherence: A prespecified analysis of the TOPIC randomized study},
  journal = {Archives of Cardiovascular Diseases Supplements},
  year = {2018},
  doi = {10.1016/j.acvdsp.2017.11.010}
}
Kostenlos starten →